PHARMACEUTICAL COMPOSITIONS COMPRISING A HMG CoA REDUCTASE INHIBITOR AND AN INORGANIC SALT, USES OF THE SAID SALT IN THE STABILIZATION OF THE SAID COMPOSITIONS AND METHODS FOR THE PRODUCTION THEREOF
The present invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically-acceptable salt thereof as the active ingredient, the composition having a coating containing a ferric oxide.
